Short answer
Zoetis (ZTS) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $2.4B (down 0.4% year over year) with net income of $591M.
Q3 2026 key financials · XBRL
- Revenue
- $2.4B
- −0.4% YoY · −3.1% QoQ
- Net income
- $591M
- −18.0% YoY · −14.5% QoQ
- EPS (diluted)
- $1.43
- −12.3% YoY · −13.9% QoQ
Source: XBRL data from the Zoetis (ZTS) Q3 2026 10-Q on SEC EDGAR. USD.
Zoetis Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $2,391M, down $31M or 1% YoY, operational revenue down 2%
- Q3 cost-of-sales margin 70.8% vs 71.2% YoY, gross margin U.S. 82.2% vs 83.2%, International 68.9% vs 68.2%
- Best segment International: revenue $1,116M, up 4%; worst U.S.: revenue $1,246M, down 6%
- Nine-month operating cash flow $1,880M vs $2,056M; financing outflows $2,371M, including $1,659M share repurchases
- Headwinds: softer companion-animal demand, generic competition, tariffs, inflation, geopolitical uncertainty and foreign-exchange volatility
Risk Factors
- No material changes to risk factors disclosed in Zoetis’s 2025 Form 10-K
- Regulatory compliance risk: Existing 10-K risks remain incorporated by reference
- Operational risk: Existing MD&A operating-environment risks remain relevant to results
- Financial risk: Existing 10-K financial-condition risks remain unchanged
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Zoetis quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.